Abbott Laboratories buy UBS Group AG
Start price
17.10.24
/
50%
€108.52
Target price
17.10.25
€134.85
Performance (%)
1.35%
End price
18.10.25
€109.98
Summary
This prediction ended on 18.10.25 with a price of €109.98. With a performance of 1.35%, the BUY prediction by UBS_Group_AG for Abbott Laboratories closed with a slight gain. UBS_Group_AG has a follow-up prediction for Abbott Laboratories where he still thinks Abbott Laboratories is a Buy. Dividends of €0.57 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Abbott Laboratories | 1.296% | 1.296% | -15.329% |
| iShares Core DAX® | -0.046% | 5.960% | 7.403% |
| iShares Nasdaq 100 | 0.922% | 3.693% | 28.138% |
| iShares Nikkei 225® | 3.014% | 6.638% | 48.886% |
| iShares S&P 500 | -0.359% | 2.747% | 22.530% |
Comments by UBS_Group_AG for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at UBS Group AG from $143.00 to $146.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
In the thread Trading Abbott Laboratories
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Current prediction by UBS_Group_AG for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€81.00
21.04.26
21.04.26
€114.62
21.04.27
21.04.27
20.22%
22:25
22:25
Stopped prediction by UBS_Group_AG for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€113.50
23.01.25
23.01.25
€142.08
23.01.26
23.01.26
-19.76%
24.01.26
24.01.26
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.04
20.04.23
20.04.23
€118.42
20.04.24
20.04.24
-1.53%
21.04.24
21.04.24